Chemoinformaics analysis of cis-2,6-Dimethyl-1-methylenecyclohexane
| Molecular Weight | 124.227 | nRot | 0 |
| Heavy Atom Molecular Weight | 108.099 | nRig | 7 |
| Exact Molecular Weight | 124.125 | nRing | 1 |
| Solubility: LogS | -3.375 | nHRing | 0 |
| Solubility: LogP | 3.223 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 25.6987 |
| nHD | 0 | BPOL | 16.0513 |
| QED | 0.435 |
| Synth | 3.602 |
| Natural Product Likeliness | 1.494 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.002 |
| HIA | 0.003 |
| CACO-2 | -4.379 |
| MDCK | 0.0000218 |
| BBB | 0.926 |
| PPB | 0.793506 |
| VDSS | 2.345 |
| FU | 0.244096 |
| CYP1A2-inh | 0.881 |
| CYP1A2-sub | 0.461 |
| CYP2c19-inh | 0.184 |
| CYP2c19-sub | 0.833 |
| CYP2c9-inh | 0.07 |
| CYP2c9-sub | 0.26 |
| CYP2d6-inh | 0.07 |
| CYP2d6-sub | 0.414 |
| CYP3a4-inh | 0.165 |
| CYP3a4-sub | 0.31 |
| CL | 8.181 |
| T12 | 0.252 |
| hERG | 0.013 |
| Ames | 0.011 |
| ROA | 0.236 |
| SkinSen | 0.183 |
| Carcinogencity | 0.661 |
| EI | 0.989 |
| Respiratory | 0.94 |
| NR-Aromatase | 0.089 |
| Antiviral | No |
| Prediction | 0.954238 |